CAS: 1150701-66-8
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | 1-[(3,4-dichlorophenyl)methyl]-N-[4-(hydroxymethyl)phenyl]-5-methyl-1H-1,2,3-triazole-4-carboxamide REF: AN-AG008TPICAS: 1150701-66-8 | 98% | A consultar | Lun 13 May 24 |
 | GSK1940029 REF: TM-T5427CAS: 1150701-66-8 | 99.48% | 119,00 €~1.193,00 € | Mar 21 May 24 |
 | GSK1940029 REF: 3D-AWB70166CAS: 1150701-66-8 | Min. 95% | A consultar | Mar 25 Jun 24 |
![1-[(3,4-dichlorophenyl)methyl]-N-[4-(hydroxymethyl)phenyl]-5-methyl-1H-1,2,3-triazole-4-carboxamide](https://static.cymitquimica.com/products/AN/thumb/AG008TPI.jpg)
1-[(3,4-dichlorophenyl)methyl]-N-[4-(hydroxymethyl)phenyl]-5-methyl-1H-1,2,3-triazole-4-carboxamide
CAS:1150701-66-8
Fórmula:
C18H16Cl2N4O2
Pureza:
98%
Peso molecular:
391.2512
Ref: AN-AG008TPI
| 1mg | 177,00 € | |
| 5mg | 484,00 € | |
| 10mg | A consultar | |
| 25mg | A consultar | |
| 50mg | A consultar | |
| 100mg | A consultar |
Entrega estimada en Estados Unidos, el Lunes 13 de Mayo de 2024
GSK1940029
CAS:1150701-66-8
GSK1940029 (SCD inhibitor 1) is a stearoyl-coa desaturase (SCD) inhibitor.
Fórmula:
C18H16Cl2N4O2
Pureza:
99.48%
Forma y color:
Solid
Peso molecular:
391.25
Ref: TM-T5427
| 1mg | 119,00 € | |
| 5mg | 245,00 € | |
| 10mg | 369,00 € | |
| 25mg | 616,00 € | |
| 50mg | 881,00 € | |
| 100mg | 1.193,00 € | |
| 1ml*10 (DMSO) | 269,00 € |
Entrega estimada en Estados Unidos, el Martes 21 de Mayo de 2024
GSK1940029
CAS:1150701-66-8
GSK1940029 is a novel anti-inflammatory drug with a potency of about 150 times that of …
Fórmula:
C18H16Cl2N4O2
Pureza:
Min. 95%
Peso molecular:
391.25 g/mol
Ref: 3D-AWB70166
| 1mg | A consultar | |
| 5mg | A consultar | |
| 10mg | A consultar | |
| 25mg | A consultar | |
| 50mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 25 de Junio de 2024
